Jackson Andrew C.

Jackson Andrew C. is listed in filings as Chief Financial Officer at Calidi Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 5, 2025, including purchase activity. Recent filings connect the profile to Calidi Biotherapeutics, Inc. (CLDI). The current snapshot covers public activity from Jun 20, 2024 to Sep 5, 2025. Reported amounts are shown as $47.4K to $58.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.